NCT04053218

Brief Summary

Globally, in 2011, 52 million children under 5 years old suffered from acute malnutrition, and a further 165 million children showed evidence of chronic undernutrition or stunting. It was also estimated that 3.1 million children died in 2011 of malnutrition related causes. The survivors, due to deprivation of critical nutrients in the most important period of development and growth, are left with permanent damage, including an increased risk of cardio-metabolic disease, poorer educational achievement and diminished earning potential. In Jamaica in 2012, 2.5% of children were moderately or severely underweight (more than two standard deviations below weight-for-age by international reference populations), falling from as high as 8.9% in 1993. Though there have been modest reductions in the incidence of acute malnutrition in Jamaica over the past 20 years, the risk remains high in poor families and among children who are being weaned. Hence, the problem is an ongoing one and we have a significant pool of survivors of childhood malnutrition who have now reached adulthood and face the consequences of early nutrient deprivation. The brain is particularly vulnerable to the effects of malnutrition and studies have demonstrated both structural (brain atrophy) and functional (cognitive impairment and poor academic achievement) changes. This evidence, however, has been mainly in later childhood and adolescence. In addition, there is local data that suggests that cardio-metabolic risk factors are increased in these adult survivors, which are well-described precursors of cerebrovascular disease and cognitive impairment. Therefore, in adulthood there may be accelerated cognitive decline due to a poor cardio-metabolic profile superimposed on pre-existing brain injury. We hypothesise that there are differences in cognitive function (poorer memory and executive function)and emotional responses in adult survivors of childhood malnutrition compared to those not exposed to early childhood malnutrition. There is evidence suggesting that aerobic exercise and omega-3 supplementation have some benefit in reversing cognitive decline in older adults, but they have not been investigated in survivors of childhood malnutrition.Hence, we propose to introduce a six month intervention of supervised aerobic exercise and omega-3 supplementation, and will compare cognitive function pre and post intervention/placebo between malnutrition survivors and controls.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2018

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2018

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 7, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 12, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2020

Completed
Last Updated

August 12, 2019

Status Verified

August 1, 2019

Enrollment Period

2.6 years

First QC Date

August 7, 2019

Last Update Submit

August 9, 2019

Conditions

Keywords

Adult survivors of severe acute malnutritionCognition

Outcome Measures

Primary Outcomes (1)

  • Cognition

    NIH Toolbox Computerized Cognitive Battery

    Six months

Secondary Outcomes (1)

  • Emotional disturbances

    Six months

Other Outcomes (4)

  • Glucose impairment

    Six months

  • Lipid metabolism

    Six months

  • Body fat changes

    Six months

  • +1 more other outcomes

Study Arms (2)

Exercise and supplement

ACTIVE COMPARATOR

Supervised aerobic exercise three times weekly and daily omega-3 supplements

Combination Product: Exercise plus omega-3 supplement

Placebo

PLACEBO COMPARATOR

Olive oil capsules. No supervised exercise but written recommendations for daily physical activity from the American Heart Association

Dietary Supplement: Placebo

Interventions

Supervised aerobic exercise and omega-3 supplement

Exercise and supplement
PlaceboDIETARY_SUPPLEMENT

Olive oil placebo

Placebo

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • SAM survivors, both males and females and between the ages of 20 and 50 years
  • Community controls will be identified from the same street address as the cases and matched for sex, age ±5 years.

You may not qualify if:

  • Pregnancy
  • Unstable angina or myocardial infarction diagnosed within 3 months;
  • Heart failure (New York Heart Association category 2) or significant valvular dysfunction;
  • Peripheral arterial disease with claudication, major orthopaedic, chronic pain, or neuromuscular disorders restricting exercise;
  • Pulmonary or renal failure;
  • Poorly controlled hypertension (\>190/110 mmHg) on two separate occasions, or type 2 diabetes mellitus, or type 1 diabetes mellitus regardless of control;
  • Recent hospitalisation for severe disease or surgery;
  • Regularly exercises at moderate or vigorous intensity for more than 30 minutes three times or more per week;
  • Is currently taking daily omega-3 supplements for over two weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of the West Indies

Kingston, Jamaica

RECRUITING

Related Publications (4)

  • Francis-Emmanuel PM, Thompson DS, Barnett AT, Osmond C, Byrne CD, Hanson MA, Gluckman PD, Forrester TE, Boyne MS. Glucose metabolism in adult survivors of severe acute malnutrition. J Clin Endocrinol Metab. 2014 Jun;99(6):2233-40. doi: 10.1210/jc.2013-3511. Epub 2014 Feb 11.

    PMID: 24517147BACKGROUND
  • Tennant IA, Barnett AT, Thompson DS, Kips J, Boyne MS, Chung EE, Chung AP, Osmond C, Hanson MA, Gluckman PD, Segers P, Cruickshank JK, Forrester TE. Impaired cardiovascular structure and function in adult survivors of severe acute malnutrition. Hypertension. 2014 Sep;64(3):664-71. doi: 10.1161/HYPERTENSIONAHA.114.03230. Epub 2014 Jun 30.

    PMID: 24980666BACKGROUND
  • Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005381. doi: 10.1002/14651858.CD005381.pub3.

    PMID: 18646126BACKGROUND
  • Dangour AD, Allen E, Elbourne D, Fletcher A, Richards M, Uauy R. Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. J Nutr Health Aging. 2009 Mar;13(3):198-202. doi: 10.1007/s12603-009-0057-2.

    PMID: 19262951BACKGROUND

MeSH Terms

Conditions

Severe Acute MalnutritionCognitive DysfunctionAffective Symptoms

Interventions

Exercise

Condition Hierarchy (Ancestors)

MalnutritionNutrition DisordersNutritional and Metabolic DiseasesCognition DisordersNeurocognitive DisordersMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Terrence E Forrester, DM, PhD

    University of the West Indies, Mona Campus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dean, Faculty of Medicine

CONTACT

Terrence E Forrester, DM, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participant will be unaware of whether the capsules are supplement or placebo. The investigators will know that all persons in the exercise group will receive omega-3 supplements and that those not exercising will be receiving placebo capsules.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be enrolled in one of two groups, exercise and omega-3 supplementation or placebo group. Subjects and controls in the first group will receive supervised aerobic exercise on a treadmill, targeting 75-85% heart rate reserve for 45 minutes per session, three days per week. Each participant's heart rate reserve will be calculated using the formula: Heart rate reserve=maximal heart rate - resting heart rate. Each participant in this group will also receive an omega-3 supplement containing 2 grams /day. The placebo group will receive 2 grams of olive oil (mainly oleic acid, a monounsaturated fatty acid) and standardised health education, face-to-face and written (American Heart Association educational materials), including recommendations for regular physical activity and nutrition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2019

First Posted

August 12, 2019

Study Start

January 15, 2018

Primary Completion

September 7, 2020

Study Completion

December 14, 2020

Last Updated

August 12, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations